Oncternal Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCT and other ETFs, options, and stocks.About ONCT
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534.
CEOJames B. Breitmeyer
CEOJames B. Breitmeyer
Employees27
Employees27
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees27
Employees27
ONCT Key Statistics
Market cap26.58M
Market cap26.58M
Price-Earnings ratio-0.65
Price-Earnings ratio-0.65
Dividend yield—
Dividend yield—
Average volume3.27K
Average volume3.27K
High today$8.98
High today$8.98
Low today$8.98
Low today$8.98
Open price$8.98
Open price$8.98
Volume1.05K
Volume1.05K
52 Week high$13.14
52 Week high$13.14
52 Week low$5.57
52 Week low$5.57
ONCT News
TipRanks 5d
Oncternal Therapeutics reports inducement award under Nasdaq listing ruleOncternal Therapeutics announced the approval of an inducement award to one new employee, Anne C. Hansen, who is joining Oncternal as Senior Director, Clinical...
Yahoo Finance 6d
Analysts Estimate Aquestive Therapeutics to Report a Decline in Earnings: What to Look Out for - Yahoo FinanceWall Street expects a year-over-year decline in earnings on higher revenues when Aquestive Therapeutics (AQST) reports results for the quarter ended March 2024....
